| Filed On | Filing |
|---|---|
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
SAN CLEMENTE, Calif., November 5, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ende... |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
SAN CLEMENTE, Calif., August 6, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended ... |
| 18 May 2026 |
8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
Section 1.1 Registered Office. The registered office shall be established and maintained with Corporation Trust Company, Corporation Trusts Center, 1209 Orange Street, City of Wilmington, County of New Castle, Delaware. The Corporation T... |
| 07 May 2026 |
8-K: Results of Operations and Financial Condition
SAN CLEMENTE, Calif., May 7, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended Mar... |
| 20 Feb 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
THIS THIRD AMENDMENT TO THE ICU MEDICAL, INC. EXECUTIVE SEVERANCE PLAN (this “Third Amendment”), effective as of December 31, 2025, is made and adopted by the Compensation Committee (the “Committee”) of the Board of Directors of ICU Medi... |
| 19 Feb 2026 |
8-K: Results of Operations and Financial Condition
SAN CLEMENTE, Calif., February 19, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period end... |
| 06 Nov 2025 |
8-K: Results of Operations and Financial Condition
SAN CLEMENTE, Calif., November 6, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ende... |
| 07 Aug 2025 |
8-K: Results of Operations and Financial Condition
SAN CLEMENTE, Calif., August 7, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended ... |
| 14 May 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
THIS THIRD AMENDMENT TO THE ICU MEDICAL, INC. 2011 STOCK INCENTIVE PLAN (this “Amendment”), effective as of March 28, 2025, is made and adopted by ICU Medical, Inc., a Delaware corporation (the “Company”). Capitalized terms used but not ... |
| 08 May 2025 |
8-K: Results of Operations and Financial Condition
SAN CLEMENTE, Calif., May 8, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended Mar... |
| 27 Feb 2025 |
8-K: Results of Operations and Financial Condition
SAN CLEMENTE, Calif., February 27, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period end... |
| 12 Nov 2024 |
8-K: Results of Operations and Financial Condition
SAN CLEMENTE, Calif., November 12, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period end... |
| 02 Oct 2024 |
8-K: Departure/Election of Directors or Officers; Compensation
On September 30, 2024, the Board of Directors of ICU Medical, Inc. (the “Company”) appointed Mr. Daniel Woolson, 48, as President of the Company, effective immediately. Mr. Woolson has served as Corporate Vice President, General Manager ... |
| 07 Aug 2024 |
8-K: Results of Operations and Financial Condition
SAN CLEMENTE, Calif., August 7, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended ... |
| 16 May 2024 |
8-K: Submission of Matters to a Vote of Security Holders
At the 2024 Annual Meeting of stockholders of ICU Medical, Inc. (the "Company") held on May 15, 2024, the following proposals were voted on by the Company’s stockholders, and the results were as set forth below: |
| 07 May 2024 |
8-K: Results of Operations and Financial Condition
SAN CLEMENTE, Calif., May 7, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended Mar... |
| 29 Feb 2024 |
8-K: Departure/Election of Directors or Officers; Compensation
On February 28, 2024, Mr. William Seeger notified the board of directors (the “Board”) of ICU Medical, Inc. (the “Company”) that he will retire from the board of directors of Smiths Group plc (“Smiths”) on May 31, 2024 and, in anticipati... |
| 27 Feb 2024 |
8-K: Results of Operations and Financial Condition
SAN CLEMENTE, Calif., February 27, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended Decemb... |
| 06 Nov 2023 |
8-K: Results of Operations and Financial Condition
SAN CLEMENTE, Calif., November 6, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended Septemb... |
| 03 Nov 2023 |
8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
Section 1.1 Registered Office. The registered office shall be established and maintained with Corporation Trust Company, Corporation Trusts Center, 1209 Orange Street, City of Wilmington, County of New Castle, Delaware. The Corporation T... |
Loading...